SCHEMBL21518022

SCHEMBL21518022

C[C@H](N)c1ccc(CN2CC3(C2)CN(C(=O)O)C3)cc1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.42
▸ HTT P42858 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CYP2D6 P10635 9/20 0.41
▸ CYP3A4 P08684 4/20 0.41
▸ TSHR P16473 2/20 0.41
▸ FAAH O00519 1/20 0.40
▸ HRH3 Q9Y5N1 3/20 0.39
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ GHSR Q92847 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ KDM1A O60341 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ RCOR1 Q9UKL0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21518024 1.00 ALDH1A1 (0.42) ALDH1A1HTTSMN1; SMN2CYP2D6CYP3A4
SCHEMBL21541346 0.83 RORC (0.50) ALDH1A1HTTSMN1; SMN2CYP2D6HRH3
SCHEMBL18459272 0.83 RORC (0.50) ALDH1A1HTTSMN1; SMN2CYP2D6HRH3
SCHEMBL19179108 0.82 ALDH1A1 (0.58) ALDH1A1HTTSMN1; SMN2FAAHHRH3
SCHEMBL18426519 0.82 ALDH1A1 (0.58) ALDH1A1HTTSMN1; SMN2FAAHHRH3
SCHEMBL20101853 0.76 CYP2D6 (0.34) ALDH1A1HTTSMN1; SMN2CYP2D6CYP3A4
SCHEMBL21358346 0.76 CYP3A4 (0.58) ALDH1A1CYP2D6CYP3A4TSHRMEN1
SCHEMBL14846936 0.75 ADRB2 (0.41) ALDH1A1HTTSMN1; SMN2TSHRHRH3
SCHEMBL22158867 0.73 HRH3 (0.68) ALDH1A1HTTSMN1; SMN2CYP2D6FAAH
SCHEMBL25301235 0.71 USP2 (0.43) ALDH1A1HTTSMN1; SMN2CYP2D6CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3328866-B1 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AND THEIT USE AS MUTANT IDH1 INHIBITORS LILLY CO ELI (US) 2019-10-30 — — EP disclosed
Send feedback